Pulmatrix Inc: Slumps on discounted offering
U.S. STOCKS ON THE MOVE-Zynga, Kraft Heinz, Molson Coors, Hexo, Cancer Genetics
U.S. STOCKS ON THE MOVE-Zynga, Spirit Airlines, Pinterest, Crypto stocks
U.S. STOCKS ON THE MOVE-Spirit Airlines, Pinterest, Novavax, Zynga
Brief: Pulmatrix Announces $40 Mln Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Brief: Pulmatrix Reports Q3 Loss Per Share $0.31
Brief: Pulmatrix Announces Marketing, Distribution Partner Sensory Cloud's Commercial Launch Of FEND
Brief: Pulmatrix Says Publication Demonstrating Reduction Of Bioaerosols With Fend, An Otc Nasal Hygiene Product Designed To Cleanse Airways Of Airborne Particles
Brief: Pulmatrix Appoints Todd Bazemore To Board
Brief: Pulmatrix Says Co Raised Over $30 Mln in 2020 To Advance Three Programs
Brief: Pulmatrix Files Prospectus For Selling Stockholders To Offer, Resell 10.7 Mln Shares Of Common Stock Underlying Warrants
Brief: Pulmatrix Files Prospectus To Offer And Resell 10.7 Million Shares Of Common Stock Underlying Warrants
Brief: Pulmatrix Reports Q2 Revenue Of $3.5 Mln
Brief: Pulmatrix Expects To Initiate New Phase 2B Clinical Study Of Pulmazole, Which Would Be Of Longer Duration And Include Efficacy Primary Endpoints
Brief: Pulmatrix - In Discussions With Cipla On Termination Of Pulmazole Phase 2 Clinical Study & Initiation Of New Phase 2B/ 3 Clinical Study During In Mid-2021
Brief: Pulmatrix Inc - Announces Progress By Sensory Cloud Toward Commercial Launch Of FEND In Fall 2020
Brief: Pulmatrix Files Prospectus To Offer And Resell From Time To Time Up To 6.7 Mln Shares Of Common Stock By Selling Stockholders
Brief: Pulmatrix Reports Qtrly Loss Per Share $0.23
Brief: Pulmatrix Inc says Effective April 21, Michael J. Higgins Succeeded Mark Iwicki As Chairman Of Board